ESPE Abstracts (2024) 98 P2-345

ESPE2024 Poster Category 2 Late Breaking (107 abstracts)

Association between maternal and fetal Small Chain Fatty Acids and offspring anthropometry during the first year of life in pregnancies with GDM: MySweetheart study

Maria-Christina Antoniou* 1 , Dan Yedu Quansah* 2 , Sybille Schenk 2 , Antje Horsch 3,4 , Virginie Mansuy-Aubert** 5 & Jardena Jacqueline Puder** 2


1Unit of Pediatric Endocrinology and Diabetology, Pediatric Service, Woman-Mother-Child Department, Lausanne University Hospital, Lausanne, Switzerland. 2Obstetric Service, Woman-Mother-Child Department, Lausanne University Hospital, Lausanne, Switzerland. 3Institute of Higher Education and Research in Healthcare (IUFRS), University of Lausanne, Lausanne, Switzerland. 4Neonatology Service, Woman-Mother-Child Department, Lausanne University Hospital, Lausanne, Switzerland. 5Biomedical Sciences Department, University of Lausanne, Lausanne, Switzerland *Maria-Christina Antoniou and Dan Yedu Quansah contributed equally ** Virginie Mansuy-Aubert and Jardena Jacqueline Puder contributed equally


Introduction: Gestational diabetes mellitus (GDM) is often accompanied by gut dysbiosis, which typically includes a decrease in short chain fatty acid (SCFA)-producing genera. Maternal SCFAs have been found to influence placental immunometabolism and fetal development. The aims of this study were: a) to investigate the associations between maternal and fetal (cord blood-umbilical artery) SCFA levels and offspring anthropometry during the first year of life in pregnancies with GDM, and b) to assess whether the impact of these associations is sex-dependent.

Methods: In this prospective secondary analysis of the MySweetheart study, we included 193 women with GDM and their offspring. Maternal and fetal (n = 39) predictors consisted of serum levels of SCFA including Acetate, Propionate, Butyrate and Crotonic acid at 24-32 weeks of gestational age (GA) and in the cord blood. Offspring outcomes were weight and height z-scores, body mass Index (BMI), small and large for gestational age (SGA, LGA) at birth, as well as weight, height and BMI z-scores at 6-8 weeks and 1 year. Associations were adjusted for maternal age, pre-pregnancy BMI, breastfeeding status (yes/no), and infant age and sex where appropriate.

Results: Mean maternal pre-pregnancy was BMI 25.9 ± 5.6 kg/m2. Mean GA at the 1st GDM visit was 29 ± 2.4 weeks. GA at delivery was 39.7 ± 1.1 weeks, with a mean weight z-score of 0.18 ± 1.1 SD; 11.8% of offspring were LGA. At 6-8 weeks, and 1 year of age, mean offspring BMI z-score was -0.20 ± 1.3 SD, and 0.23 ± 1.1SD. Maternal and fetal SCFA levels were not significantly correlated. In multivariate analyses, maternal 3rd trimester crotonic acid and cord blood proprionate were positively associated with LGA and length z-score at birth respectively. Maternal 3rd trimester acetate and cord blood crotonic acid were inversely associated with offspring length and BMI z-score at 6-8 weeks of age respectively. Sex stratified analyses showed differential results, with associations between maternal and cord blood SCFA being observed exclusively in boys, both at 6-8 weeks and 1 year (p ≤0.043).

Conclusion: Our data suggest that maternal and fetal SCFAs may play a role in determining fetal growth in both female and male offspring, whereas their impact on 1st year growth trajectories seems to be more relevant in male offspring.

Volume 98

62nd Annual ESPE (ESPE 2024)

Liverpool, UK
16 Nov 2024 - 18 Nov 2024

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.